Persistent Blister on Hand for 1 Year: Evaluation and Management
A blister persisting for one year on the hand is not a simple friction blister and requires immediate dermatologic evaluation with skin biopsy and direct immunofluorescence to rule out autoimmune blistering disorders, particularly bullous pemphigoid or pemphigus vulgaris.
Diagnostic Approach
Key Clinical Features to Assess
A persistent blister lasting one year demands investigation for:
- Autoimmune blistering diseases: Bullous pemphigoid (most common in elderly), pemphigus vulgaris, or dyshidrosiform pemphigoid (rare variant localized to hands/feet) 1
- Blister characteristics: Tense blisters suggest bullous pemphigoid; flaccid blisters suggest pemphigus
- Associated symptoms: Intense pruritus preceding blistering by weeks-to-months suggests pre-bullous phase of bullous pemphigoid 2
- Distribution: Localized hand involvement may indicate dyshidrosiform pemphigoid variant 1
Essential Diagnostic Workup
Perform these tests immediately:
- Skin biopsy for histopathology: Identifies subepidermal vs. intraepidermal split 3
- Direct immunofluorescence (DIF): Detects antibody deposition pattern (linear basement membrane zone in bullous pemphigoid; intercellular in pemphigus)
- Indirect immunofluorescence (IIF): Detects circulating anti-basement membrane zone antibodies 2
- Serum ELISA: For specific autoantibodies (BP180, BP230, desmoglein 1/3)
Management Based on Diagnosis
If Bullous Pemphigoid (Localized to Hand)
First-line treatment for localized disease 4:
- Topical clobetasol propionate 0.05% cream: 10g daily applied to affected areas
- Continue until disease control (no new blisters, healing of lesions)
- Then taper to maintenance: 10g once weekly for 8 months
- Avoid systemic steroids for localized disease—topical therapy has superior safety profile 4
If inadequate response after 1-3 weeks, consider:
- Oral prednisone 0.5-0.75 mg/kg/day combined with topical therapy 4
- Add steroid-sparing agent: dapsone (effective in dyshidrosiform variant 1), azathioprine, or mycophenolate mofetil
If Pemphigus Vulgaris
First-line treatment 5:
Oral prednisolone 0.5-1 mg/kg/day for milder/localized cases
Combine immediately with adjuvant immunosuppressant:
- Azathioprine 2-3 mg/kg/day (check TPMT first)
- Mycophenolate mofetil 2-3g/day
- Rituximab (2 x 1g infusions, 2 weeks apart) shows superior efficacy: 89% complete remission vs. 28% with prednisolone alone at 2 years 5
Taper prednisolone once remission achieved (no new blisters, healing of majority of lesions)
Aim to reduce to ≤10mg daily
Assess osteoporosis risk immediately when starting corticosteroids 5
Critical Pitfalls to Avoid
Do not treat as simple friction blister: Friction blisters heal within days to weeks 6, 7. One-year persistence mandates autoimmune workup.
Do not delay biopsy: Clinical diagnosis alone is insufficient. DIF is essential to distinguish between autoimmune blistering disorders 3.
Do not use high-dose systemic steroids for localized bullous pemphigoid: Mortality and morbidity are higher with systemic steroids compared to potent topical steroids for localized disease 4.
Do not stop treatment prematurely: Relapse rates are 47% when treatment stopped after only 1 year in pemphigus 5. Complete remission off-therapy takes 3-10 years.
Do not use corticosteroids alone for pemphigus: Always combine with adjuvant immunosuppressant from the start to reduce cumulative steroid exposure and improve long-term remission rates 5.
When to Refer
Immediate dermatology referral is mandatory for:
- Any blister persisting beyond 2-3 weeks
- Suspected autoimmune blistering disease
- Biopsy interpretation and treatment initiation
- Multidisciplinary management if third-line therapies needed